Ventilator-associated pneumonia due to meticillin-resistant Staphylococcus aureus: Risk factors and outcome in a large general hospital

Journal of Hospital Infection

Volumn 80, Issue 2, 2012, Pages 150-155

  Bouza, E ^a,b,c   Giannella, M ^a,c   Bunsow, E ^a   Torres, M V ^a,c   Perez Granda M J ^a   Martin Rabadan P ^a,c   Munoz P ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Methicillin resistance; Staphylococcus aureus; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CIPROFLOXACIN; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL SURGERY; ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG COST; ENTEROBACTERIACEAE; FEMALE; GENERAL HOSPITAL; HAEMOPHILUS; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NEUROSURGERY; NONHUMAN; OUTCOME ASSESSMENT; PLEURA EFFUSION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; FEMALE; HOSPITALS, GENERAL; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84856009935     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.11.013     Document Type: Article

References (31)

1. Kollef M.H., Morrow L.E., Niederman M.S., et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218.
2. Hortal J., Giannella M., Perez M.J., et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intens Care Med 2009, 35:1518-1525.
3. Hortal J., Muñoz P., Cuerpo G., Litvan H., Rosseel P.M., Bouza E. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care 2009, 13:R80.
4. Park D.R. The microbiology of ventilator-associated pneumonia. Respir Care 2005, 50:742-763. discussion 63-65.
5. Jones R.N. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010, 51(Suppl. 1):S81-87.
6. Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R.S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
7. Rello J., Torres A., Ricart M., et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994, 150(6 Pt 1):1545-1549.
8. Combes A., Luyt C.E., Fagon J.Y., et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 2004, 170:786-792.
9. Zahar J.R., Clec'h C., Tafflet M., et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?. Clin Infect Dis 2005, 41:1224-1231.
10. Shorr A.F., Combes A., Kollef M.H., Chastre J. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006, 34:700-706.
11. Shorr A.F., Tabak Y.P., Gupta V., Johannes R.S., Liu L.Z., Kollef M.H. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006, 10:R97.
12. McCabe W.R., Davis J.C., Andersen B.R., Jackson G.G. Acritical evaluation of clinical and laboratory studies. NEngl J Med 1960, 263:927-934.
13. Charlson M.E., Sax F.L., MacKenzie C.R., Braham R.L., Fields S.D., Douglas R.G. Morbidity during hospitalization: can we predict it?. JChronic Dis 1987, 40:705-712.
14. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
15. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
16. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
17. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Resp Dis 1991, 143(5 Pt 1):1121-1129.
18. Guidelines for performance of respiratory tract cultures 2004, ASM Press, Washington, DC. M. York, P. Gilligan (Eds.).
19. Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement 2005, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA.
20. Fridkin S.K., Hill H.A., Volkova N.V., et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002, 8:697-701.
21. Hidron A.I., Edwards J.R., Patel J., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
22. Zilberberg M.D., Shorr A.F., Kollef M.H. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis 2008, 14:1756-1758.
23. Athanassa Z., Siempos I.I., Falagas M.E. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 2008, 31:625-632.
24. Calfee D.P., Salgado C.D., Classen D., et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl. 1):S62-80.
25. Am J Infect Control 2004, 32:470-485. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.
26. Pujol M., Corbella X., Pena C., et al. Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998, 17:622-628.
27. Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998, 157:531-539.
28. Depuydt P.O., Vandijck D.M., Bekaert M.A., et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care 2008, 12:R142.
29. Harris A.D., Karchmer T.B., Carmeli Y., Samore M.H. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001, 32:1055-1061.
30. Shorr A.F. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics 2007, 25:751-768.
31. Sarikonda K.V., Micek S.T., Doherty J.A., Reichley R.M., Warren D., Kollef M.H. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment. Crit Care Med 2010, 38:1991-1995.